Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26FV9B1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $60,081
Award facts
- Contract value 100% obligated
- $60,081.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $60,081.35 delivery order to Amerisourcebergen Drug Corp on February 26, 2026, for Cosentyx (secukinumab) 300 mg dose, 2 pen/mL.
The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical supplies to support military healthcare programs worldwide. Place of performance is Conshohocken, PA. Ultimate completion date is February 27, 2026.
Quick answers
Who was awarded contract SPE2DR26FV9B1?
SPE2DR26FV9B1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 26, 2026.
How much is contract SPE2DR26FV9B1 worth?
The government has obligated $60,081 on SPE2DR26FV9B1.
Is contract SPE2DR26FV9B1 an order under another contract?
Yes. SPE2DR26FV9B1 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV9B1 competed?
The extent of competition for SPE2DR26FV9B1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award